Ocular Therapeutix Inc (OCUL)

Jul 23, 2025

What drives Ocular Therapeutix Inc. stock priceMassive wealth growth - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Ocular Therapeutix stock hits 52-week high at $11.78 - Investing.com India

Jul 23, 2025

Jul 23, 2025

What analysts say about Ocular Therapeutix Inc. stockAccelerated wealth building - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences - GlobeNewswire

Jul 22, 2025

Jul 22, 2025

Ocular Therapeutix Inc. Stock Analysis and ForecastRecord-breaking gains - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Ocular Therapeutix Announces Participation in Upcoming Scientific Conferences Focused on Retina Innovation - Quiver Quantitative

Jul 22, 2025

Jul 22, 2025

Ocular Therapeutix Participates in Upcoming Scientific Conferences - AInvest

Jul 22, 2025

Jul 22, 2025

Ocular Therapeutix Unveils Breakthrough Diabetic Retinopathy Treatment Data Across 3 Major Eye Conferences - Stock Titan

Jul 22, 2025

Jul 22, 2025

Is Ocular Therapeutix Inc. a good long term investmentRemarkably fast returns - jammulinksnews.com

Jul 22, 2025

Jul 20, 2025

(OCUL) Trading Report - news.stocktradersdaily.com

Jul 20, 2025

Jul 19, 2025

FMR LLC's Strategic Acquisition of Ocular Therapeutix Shares: A Financial Analysis - AInvest

Jul 19, 2025

Jul 09, 2025

Ocular Therapeutix(OCUL) Soars 8.47% on Pipeline Progress - AInvest

Jul 09, 2025

Jul 07, 2025

Institutional investors control 65% of Ocular Therapeutix, Inc. (NASDAQ:OCUL) and were rewarded last week after stock increased 3.7% - simplywall.st

Jul 07, 2025

Jun 30, 2025

Ocular Therapeutix, Inc.(NasdaqGM: OCUL) dropped from Russell 3000E Index - MarketScreener

Jun 30, 2025

Jun 30, 2025

Ocular Therapeutix, Inc.(NasdaqGM: OCUL) dropped from Russell 3000E Growth Index - MarketScreener

Jun 30, 2025

Jun 29, 2025

Selling US$1.1m Of Ocular Therapeutix Stock Rewarded Insiders - 富途牛牛

Jun 29, 2025

Jun 27, 2025

Ocular Therapeutix™ Unveils New Corporate Branding, Reflecting its Transformation to a Retina-Focused Company - The Manila Times

Jun 27, 2025

Jun 26, 2025

Ocular Therapeutix Launches New Corporate Branding to Enhance Retina-Focused Mission - Nasdaq

Jun 26, 2025

Jun 25, 2025

Ocular Therapeutix (OCUL) Moves 8.6% Higher: Will This Strength Last? - Yahoo Finance

Jun 25, 2025

Jun 24, 2025

Pre-market Movers: NKTR, INM, IBIO, IBO... - RTTNews

Jun 24, 2025

Jun 23, 2025

OCUL SEC FilingsOcular Therapeut 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 23, 2025

Jun 19, 2025

Trend Tracker for (OCUL) - news.stocktradersdaily.com

Jun 19, 2025

Jun 18, 2025

Ocular Therapeutix to present at Clinical Trials at the Summit 2025 - Ophthalmology Times

Jun 18, 2025

Jun 17, 2025

Ocular Therapeutix (NASDAQ:OCUL) shareholders have earned a 33% CAGR over the last three years - Yahoo Finance

Jun 17, 2025

Jun 16, 2025

Ocular's Make-Or-Break Moment: Axpaxli Data Looms For Wet AMD Market (Upgrade) (OCUL) - Seeking Alpha

Jun 16, 2025

Jun 16, 2025

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025 | OCUL Stock News - GuruFocus

Jun 16, 2025

Jun 16, 2025

Ocular Therapeutix, Inc. to Present Clinical Trial Results and Insights at Summit 2025 in Las Vegas - Nasdaq

Jun 16, 2025

Jun 16, 2025

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025 - GlobeNewswire

Jun 16, 2025

Jun 16, 2025

Breakthrough Eye Disease Treatment Data: Ocular Therapeutix Reveals Clinical Trial Results at CTS 2025 - Stock Titan

Jun 16, 2025

Jun 11, 2025

Ocular Therapeutix Approves Key Amendments at Annual Meeting - TipRanks

Jun 11, 2025

Jun 11, 2025

Rising Leaders 2025: Namrata Saroj On The Importance Of Authenticity In Ophthalmology - insights.citeline.com

Jun 11, 2025

Jun 10, 2025

Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) 26% Jump Shows Its Popularity With Investors - simplywall.st

Jun 10, 2025

Jun 06, 2025

Trading (OCUL) With Integrated Risk Controls - news.stocktradersdaily.com

Jun 06, 2025

Jun 03, 2025

Ameriprise Financial Inc. Purchases 40,700 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

Jun 03, 2025

Jun 02, 2025

Two Sigma Investments LP Buys 45,518 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

Jun 02, 2025

Jun 02, 2025

Nuveen Asset Management LLC Has $3.54 Million Stake in Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

Jun 02, 2025

Jun 02, 2025

What is HC Wainwright’s Forecast for OCUL Q1 Earnings? - Defense World

Jun 02, 2025

Jun 01, 2025

Ocular gains as Wet AMD trial for lead asset reaches enrollment target - MSN

Jun 01, 2025

May 30, 2025

Ocular Therapeutix (NASDAQ:OCUL) Given Buy Rating at HC Wainwright - Defense World

May 30, 2025

May 30, 2025

Ocular Therapeutix (OCUL) Maintains "Buy" Rating with $15 Price Target | OCUL Stock News - GuruFocus

May 30, 2025

May 30, 2025

Millennium Management LLC Takes $3.82 Million Position in Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

May 30, 2025

May 30, 2025

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Stock Holdings Lessened by Bank of America Corp DE - Defense World

May 30, 2025

May 29, 2025

Demystifying Ocular Therapeutix: Insights From 7 Analyst Reviews - Benzinga

May 29, 2025

May 29, 2025

Ocular Therapeutix (OCUL) Advances with Axpaxli Trial Completion - GuruFocus

May 29, 2025

May 29, 2025

Ocular Therapeutix (NASDAQ:OCUL) Has Debt But No Earnings; Should You Worry? - simplywall.st

May 29, 2025